Ledger.Open graph →
SEC Form D · filed July 27, 2020

MBX Biosciences, Inc

Offering
$35.8M
Sold
$25.8M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CARMEL, IN
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Timothy K. Knickerbocker · Carmel, INExec · DirectorRichard K. Dimarchi · Carmel, INExec · DirectorPeter K. Hawryluk · Zionsville, INExec · DirectorTimothy K. Knickerbocker · Carmel, INExec · DirectorRichard K. Dimarchi · Carmel, INExec · DirectorPeter K. Hawryluk · Zionsville, INExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗